| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.24 | 2e-11 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.22 | 2e-09 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.21 | 2e-08 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-08 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.19 | 4e-08 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-07 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.2 | 2e-07 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | 0.18 | 4e-07 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.16 | 8e-07 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-06 |